Robert Mccabe, Jr. Acquires 890 Shares of National Health Investors (NYSE:NHI) Stock

National Health Investors, Inc. (NYSE:NHI) Director Robert Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction on Monday, June 15th. The stock was acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link.

National Health Investors Trading Up 1.1%

Shares of National Health Investors stock opened at $71.51 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock’s 50 day simple moving average is $76.80 and its 200-day simple moving average is $79.97. The stock has a market cap of $3.47 billion, a P/E ratio of 23.07, a P/E/G ratio of 3.80 and a beta of 0.52. National Health Investors, Inc. has a 1-year low of $67.94 and a 1-year high of $91.38.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The company had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. During the same period in the prior year, the business posted $1.15 EPS. National Health Investors’s revenue for the quarter was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts predict that National Health Investors, Inc. will post 4.93 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.1%. National Health Investors’s dividend payout ratio (DPR) is 118.71%.

Analyst Ratings Changes

Several research analysts have recently weighed in on NHI shares. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. BMO Capital Markets reduced their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday. Truist Financial dropped their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Finally, Wells Fargo & Company cut their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $84.57.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of NHI. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors in the 4th quarter valued at $27,000. EverSource Wealth Advisors LLC boosted its holdings in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new position in National Health Investors in the 4th quarter valued at about $33,000. GAMMA Investing LLC grew its position in National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new stake in National Health Investors during the fourth quarter worth about $47,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.